***Background.*** Individuals with spinal cord injury or disorder (SCI/D) are at high risk for infections and antimicrobial resistance compared to the general patient population due to factors such as frequent hospitalization, previous antibiotic use, and frequent and chronic use of invasive devices. Increasing resistance of complex infections can result in inadequate empiric prescribing. Thus, the purpose of this project was to evaluate the prevalence and resistance patterns of bacteria isolated from SCI/D patients as compared to a general patient population.

***Methods.*** Microbiology laboratory reports from October 1, 2012-September 30, 2013 for all cultures (inpatient and outpatient) obtained at a Midwestern Veterans Affairs facility were evaluated. Only the first isolate cultured from a single patient was included unless the susceptibility pattern changed. Antimicrobial susceptibility results of individual isolates were compiled into a standardized SCI/D-specific antibiogram and compared to a compiled facility-wide antibiogram using chi-square tests.

***Results.*** A total of 1,716 cultures were evaluated; where 711 were from SCI/D. Frequencies of pathogens isolated in SCI/D and facility-wide were similar; *Escherichia coli* was most frequent, followed by *Staphylococcus aureus*, Enterococcus sp., *Pseudomonas aeruginosa*, and Coagulase-Negative Staphylococcus (CoNS). The *P. aeruginosa* isolates from SCI/D were less susceptible to ciprofloxacin (46.5% vs 58.4%, p = 0.01), meropenem (55.6% vs 69.3%, p = 0.03), and tobramycin (73.6% vs 81.3%, p = 0.04). In SCI/D, *S. aureus* and CoNS isolates were less susceptible to oxacillin, (27.8% vs 50.3%, p \< 0.0001 and 21.7% vs 40.3%, p = 0.01, respectively). About three-fourths of Klebsiella sp. ESBLs and *Proteus mirabilis* ESBLs isolates were isolated from SCI/D patients.

***Conclusion.*** Although the frequencies of pathogens isolated were similar, significant differences in susceptibilities were identified for Staphylococcus sp. and *P. aeruginosa.* In addition, the frequency of ESBLs in cultures obtained from patients with SCI/D is worrisome. Differences in susceptibilities suggest that developing an SCI-unit specific antibiogram may be useful in choosing appropriate empiric treatment.
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